5-Bromo-3-nitro-4-(4-(pyridin-3-ylmethyl)piperazin-1-yl)pyridin-2-amine

Catalog No.: 
ACCEKP086
CAS No.: 
942948-39-2
Molecular Formula: 
C15H17BrN6O2
Molecular Weight: 
393.24
5-Bromo-3-nitro-4-(4-(pyridin-3-ylmethyl)piperazin-1-yl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$240.00InquiryInquiry
1g95%$702.00InquiryInquiry
5g95%$3440.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-3-nitro-4-(4-(pyridin-3-ylmethyl)piperazin-1-yl)pyridin-2-amine
IUPAC Name5-bromo-3-nitro-4-(4-(pyridin-3-ylmethyl)piperazin-1-yl)pyridin-2-amine
Molecular FormulaC15H17BrN6O2
Molecular Weight393.24
SMILESNC1=NC=C(Br)C(N2CCN(CC3=CC=CN=C3)CC2)=C1[N+]([O-])=O
InChI KeyPZLGRWHCOVRTEM-UHFFFAOYSA-N
Synonym5-Bromo-3-nitro-4-(4-(pyridin-3-ylmethyl)piperazin-1-yl)pyridin-2-amine;2-Pyridinamine, 5-bromo-3-nitro-4-[4-(3-pyridinylmethyl)-1-piperazinyl]-
CAS No.942948-39-2

Synthetic Route by SureRoute

1. ACCEKP086 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDUEB531 route compound structure diagram
    ACDUEB531942947-95-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCEKP086 route product structure diagram
    ACCEKP086942948-39-2
Inquiry

2. ACCEKP086 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCEKP086 route product structure diagram
    ACCEKP086942948-39-2
Inquiry

3. ACCEKP086 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCEKP086 route product structure diagram
    ACCEKP086942948-39-2
Inquiry

Comments (0)